OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze
Episode Details
The recent episode of the All-In Podcast featured a wide-ranging discussion led by hosts Jason Calacanis, David Friedberg, David Sacks, and Chamath Palihapitiya. They started by analyzing how OpenAI, under Sam Altman, alongside Sarah Frier and Greg Brockman, reportedly missed targets for ChatGPT. However, the company is advancing rapidly with GPT 5.5 and the Codex model, keeping them competitive against anthropic and its CEO Dario Amodei, who are managing compute constraints with Claude and Opus 4.7. Elon Musk continues to challenge the landscape with Grok and leveraging computing excess from SpaceX, all while pursuing Elon Musk's lawsuit against OpenAI. The hosts highlighted how Hyperscalers like Google (pushing Gemini), Microsoft, Amazon, Meta, and Oracle are driving a historic Capex Boom centered around Cloud Computing. This massive AI Infrastructure Buildout is creating unprecedented Energy demand for AI, prompting interest in highly efficient SLMs (Small Language Models). In the developer space, Aaron Levie criticized the hype around Vibe Coding, noting risks highlighted when a non-engineer using Cursor 2.0 accidentally deleted a codebase. In the enterprise software sector, Cybersecurity in the AI era is exploding. Executives like George Kurtz of CrowdStrike and leaders at Palo Alto Networks see immense opportunities to defend against both domestic threats and foreign models like China's Deep Seek, as well as sophisticated models like Anthropic's Mythos. Shifting to biotechnology, the conversation covered the explosive popularity of GLP-1 Agonists. Eli Lilly is seeing massive success with Tirzepatide and is now testing the next-generation peptide Retatrutide. Finally, the episode concluded with a look at the Supreme Court, where the hosts discussed oral arguments involving Bayer and the EPA. This high-stakes case is deeply influenced by the recent overturning of the Chevron Doctrine and ongoing debates over Federal Preemption.
Key Topics & People
Host of the All-In Podcast conducting the interview with Ryan Cohen.
The podcast hosting the interview with GameStop CEO Ryan Cohen.
Large cloud service providers that stand to gain an oligopoly through heavy AI regulation.
CEO of Anthropic, heavily critiqued for his political maneuvering and ideology regarding AI safety.
.jpg?width=300){kind=avatar}
.jpg?width=300){kind=avatar}
Venture capitalist and podcast host who criticizes the behavior of frontier AI labs.
Entrepreneur and host of the podcast, known for his political, geopolitical, and venture capital insights.
.jpg?width=300){kind=avatar}
Host of the All-In Podcast, referred to as Bestie or JCal, who moderates the discussion.
.jpg?width=300){kind=avatar}
CEO of OpenAI.
.jpg?width=300){kind=avatar}
Cybersecurity company whose CEO tested Anthropic's models.
A cybersecurity company and portfolio investment of Section 32.
Remote server infrastructure that faces latency challenges for high-frequency financial operations.
The evolving landscape of digital defense and offense driven by artificial intelligence models.
_(cropped).jpg?width=300){kind=avatar}
President and co-founder of OpenAI, known for his foresight on compute needs.
An OpenAI model focused on coding assistance that rapidly scaled to 5 million users.
CFO of OpenAI who discusses the company's recent fundraising, infrastructure strategies, and market positioning.
The practice of building software and applications using AI language models rather than writing code manually.
The massive capital expenditure cycle dedicated to constructing data centers, deploying GPUs, and powering AI development.
A new triple-agonist peptide drug by Eli Lilly showing spectacular fat loss and liver health improvements.
The principle that federal laws supersede state laws, heavily debated in current corporate product liability cases.
A recently overturned legal precedent regarding federal agency deference that impacts corporate regulations.
The highest federal court in the US, currently ruling on complex corporate regulation cases.
A class of peptide medications that manage blood sugar and drive significant weight loss.
A dual-agonist GLP-1 and GIP drug marketed by Eli Lilly for metabolic health.
CEO of CrowdStrike, discussing the immense enterprise demand for AI-driven security tools.
Tech CEO who criticized the unrealistic expectations of unmanaged vibe coding by non-engineers.
An AI-assisted code editor used heavily for agentic software development and vibe coding.
More efficient, localized AI models designed to reduce energy inference costs.
The massive electrical power required to operate advanced AI compute facilities.
The massive surge in capital expenditures by tech companies to build AI capabilities.
A high-stakes trial where Elon Musk accuses OpenAI of unjust enrichment and abandoning its nonprofit mission.